Tag: Orange Book patents

Understanding Patent Disputes in Generic Drug Markets: How Litigation Affects Access to Affordable Medicines

Patent disputes in generic drug markets affect drug access and costs. The Hatch-Waxman Act sets rules for patent challenges, but brand companies often use tactics to delay generics. Recent cases like Teva vs. Amneal show courts reining in improper listings. The FTC is cracking down, while settlements sometimes speed up generic entry. This explains how litigation shapes affordable medicine availability.